Cordlife Hong Kong - Macau
AboutParent bank: Cordlife Hong Kong
Fleet Company Limited is the appointed agent of Cordlife in Macau. Cordlife Group Limited owns and operates five cord blood laboratories in Singapore, Hong Kong, India, Indonesia and the Philippines. Cordlife (Hong Kong) Limited is located in Hong Kong Science Park and provides a full suite of cord blood and umbilical cord tissue banking services, which are accredited by AABB and ISO. Cordlife offers CellOptima™, a patented technology from Singapore. CellOptima™ enables the isolation of two types of stem cells from umbilical cord lining namely, Epithelial stem cells (EpSCs) and Mesenchymal stem cells (MSCs). This technology is exclusively available at Cordlife in Hong Kong.
Cordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns over 30% of Stemlife Malaysia. At present the laboratories in Singapore, Hong Kong, and India are accredited by AABB (formerly known as American Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:
Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines
Cordlife Group Limited was established in Singapore in 2001 to provide a full suite of cord blood and (subsequently) tissue banking services which include the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. Cordlife has grown rapidly from a fledging start-up company into a multi-national corporation. In 2005, Cordlife established its first overseas cord blood processing and storage facility in Hong Kong. The ISO certified facility, with a storage capacity for 50,000 cord blood and umbilical cord units, is Hong Kong’s largest and most advanced stem cell facility. In 2011, Cordlife introduced the patented technology, CellOptima™, which is exclusively available at Cordlife in Hong Kong, to isolate two types of stem cells from umbilical cord – Epithelial stem cells and Mesenchymal Stem Cells (MSC).
Cordlife provides personalized collection kits for clients upon enrollment. The main components of the kit are:
- Sterile, single use cord blood collection bag (JMS Cord Blood Bag with anticoagulant CPDA-1),
- Providone Iodine swabsticks for antiseptic preparation of the umbilical cord's surface prior to collecting the cord blood, to reduce chance of contamination.
Cordlife's container is specially designed to provide thermal insulation and validated to maintain optimal temperature for cord blood during transportation from hospital to Cordlife HK processing laboratory.
Cordlife provides dedicated staff to pick up the cord blood or cord tissue samples from Hong Kong / Macau hospitals upon notification.
Cordlife is the only private cord blood bank in Hong Kong that utilizes the Sepax™ fully automated processing system from Biosafe for cord blood processing. Sepax™ technology relies on a light beam to sense the density gradient between different cell layers (or fractions) after the blood has been gently spun in a centrifuge. Sepax™ processing kit is sterile, functionally closed and individually packed for single use only. According to Cordlife validation studies, Sepax™ is able to recover as high as 99.64% of nucleated cells from cord blood.
Final product stored is the nucleated cells in “buffy coat” fraction (mainly white blood cells and stem cells).
Cordlife uses FDA-approved dual-compartment cryobags (80% and 20% sections) and two integrally attached segments used for future unit testing. In addition, each cryobag is sealed inside an overwrap layer as an extra protection against possible cross contamination. The cord blood units are stored in an MVE vapor phase storage system i.e. units are suspended above a pool of liquid nitrogen that creates a vapor-phase environment, with temperature as cold as the cryogenic liquid.
Licensing & Accreditation
- Cordlife's in-depth knowledge of cord blood banking practices and standards has attained accreditation under the international quality standards of American Association of Blood Banks (AABB) and International Organization for Standardization (ISO).
- Cordlife Hong Kong is accredited by the College of American Pathologists (CAP) for their screening laboratory which can detect more than 100 metabolic disorders from urine specimens of newborns. This service is offered in Hong Kong, Indonesia, and the Philippines.
Cordlife and its associates have released cord blood units to approximately 300 families to treat over 50 indications at over 50 institutions globally. In January 2011, Cordlife became the only private cord blood bank in Hong Kong to have released a cord blood unit for autologous therapy (where the baby recives its own stem cells) to treat neuroblastoma. That cord blood transplant took place in Queen Mary Hospital, and was performed using a cord blood unit that had been cryopreserved in the Cordlife Hong Kong facility for 29 months.
Cordlife Quality Guarantee – if the cord blood unit has no viability at the point of transplantation, Cordlife will compensate a matching sample or US$25,000 at maximum.
Please visit the Cordlife Hong Kong Price & Enrollment page for the latest prices and discounts. Flexible payment plans are available for 5, 10 and 18-year plans. Selected credit cards are eligible for 12-month interest-free installment payments.
Cordlife is the only stem cell bank in Hong Kong that can isolate two types of stem cells from the baby’s umbilical cord – Epithelial stem cells (EpSCs) and Mesenchymal stem cells (MSCs). Cordlife screening centre can detect more than 100 metabolic disorders from the urine specimens of newborns.